Department of Hypertension, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Department of Cardiology, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Vasc Med. 2024 Oct;29(5):470-482. doi: 10.1177/1358863X241261368. Epub 2024 Aug 30.
Renin and prorenin promote the proliferation of vascular smooth muscle cells (VSMCs) through the (pro)renin receptor, or (P)RR, to promote restenosis occurrence. This study aimed to explore whether prorenin promoted the proliferation of VSMCs in a (P)RR-mediated Ang II-independent manner. : Losartan and PD123319 were used to block the interaction between (P)RR and angiotensin in vitro. Cells were treated with renin, platelet-derived growth factor (PDGF), or RNAi-(P)RR, either jointly or individually. Cell proliferation was measured via Cell Counting Kit-8 (CCK-8) and flow cytometry methods; moreover, real-time polymerase chain reaction (RT-PCR) and Western blot (WB) assays were used to detect the expression of cyclin D1, proliferating cell nuclear antigen (PCNA), (P)RR, NOX1, and phosphatidylinositol 3-kinase (PI3K)/AKT signaling proteins. Immunofluorescence staining was conducted to measure the expression of (P)RR, and the levels of renin, PDGF-BB, inflammatory factors, and oxidative stress were determined by using enzyme-linked immunosorbent assay (ELISA). Moreover, a balloon catheter was used to enlarge the carotid artery of the Sprague Dawley rats. PRO20 was applied to identify angiotensin II (Ang II). The hematoxylin and eosin, RT-PCR, and WB results validated the cell assay results. : Renin promoted the proliferation of rat VSMCs by enhancing cell viability and cell cycle protein expression when Ang II was blocked, but silencing (P)RR inhibited this effect. Furthermore, renin enhanced NOX1-mediated oxidative stress and inflammation by activating the extracellular signal-regulated kinase 1/2 (ERK1/2)-AKT pathway in vitro. Similarly, the inhibition of (P)RR resulted in the opposite phenomenon. Importantly, the inhibition of (P)RR inhibited neointimal hyperplasia in vivo after common carotid artery injury by restraining NOX1-mediated oxidative stress through the downregulation of the ERK1/2-AKT pathway. The animal study confirmed these findings. : Renin and (P)RR induced VSMC proliferation and neointimal hyperplasia by activating oxidative stress, inflammation, and the ERK1/2-AKT pathway in an Ang II-independent manner.
肾素和前肾素通过(前)肾素受体(或 P)RR 促进血管平滑肌细胞(VSMCs)的增殖,从而促进再狭窄的发生。本研究旨在探讨前肾素是否通过 PRR 介导的血管紧张素 II 非依赖性方式促进 VSMCs 的增殖。
在体外使用洛沙坦和 PD123319 阻断 PRR 与血管紧张素的相互作用。用肾素、血小板衍生生长因子(PDGF)或 RNAi-PRR 单独或联合处理细胞。通过细胞计数试剂盒-8(CCK-8)和流式细胞术方法测量细胞增殖;此外,实时聚合酶链反应(RT-PCR)和蛋白质印迹(WB)检测 cyclin D1、增殖细胞核抗原(PCNA)、(P)RR、NOX1 和磷脂酰肌醇 3-激酶(PI3K)/AKT 信号蛋白的表达。免疫荧光染色测量(P)RR 的表达,酶联免疫吸附试验(ELISA)测定肾素、PDGF-BB、炎症因子和氧化应激水平。此外,使用球囊导管扩大 Sprague Dawley 大鼠的颈总动脉。PRO20 用于鉴定血管紧张素 II(Ang II)。苏木精和伊红、RT-PCR 和 WB 结果验证了细胞试验结果。
当阻断血管紧张素 II 时,肾素通过增强细胞活力和细胞周期蛋白表达促进大鼠 VSMCs 的增殖,但沉默 PRR 抑制了这种作用。此外,肾素通过激活细胞外信号调节激酶 1/2(ERK1/2)-AKT 通路在体外增强 NOX1 介导的氧化应激和炎症。同样,抑制 PRR 导致相反的现象。重要的是,通过下调 ERK1/2-AKT 通路,抑制 PRR 抑制了颈总动脉损伤后体内的新生内膜增生,从而抑制了 NOX1 介导的氧化应激。动物研究证实了这些发现。
总之,肾素和 PRR 通过激活氧化应激、炎症和 ERK1/2-AKT 通路,在血管紧张素 II 非依赖性方式下诱导 VSMC 增殖和新生内膜增生。